Binding molecules capable of neutralizing rabies virus and uses thereof

Details for Australian Patent Application No. 2005250163 (hide)

Owner Crucell Holland B.V.

Inventors De Kruif, Cornelis Adriaan; Kramer, Robert Arjen; Marissen, Willem Egbert; Bakker, Alexander Berthold Hendrik

Agent Davies Collison Cave

Pub. Number AU-B-2005250163

PCT Pub. Number WO2005/118644

Priority 60/575,023 27.05.04 US; PCT/ EP2004/052772 03.11.04 EP; PCT/ EP2004/052286 23.09.04 EP; PCT/ EP2004/050943 27.05.04 EP; PCT/ EP2005/050953 03.03.05 EP; PCT/ EP2004/051661 29.07.04 EP; PCT/ EP2005/050310 25.01.05 EP

Filing date 26 May 2005

Wipo publication date 15 December 2005

Acceptance publication date 25 August 2011

International Classifications

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/118644 Priority application(s): WO2005/118644

25 August 2011 Application Accepted

  Published as AU-B-2005250163

22 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005250170-Peptides for inducing a CTL and/or HTL response to hepatitis C virus

2005250161-Tetrasubstituted imidazole derivatives as cannabinoid CB1 receptor modulators with a high CB1/CB2 receptor subtype selectivity